Zenith Drugs Limited enhanced investor transparency by hosting a Stock Knocks session to discuss its business model, growth strategy, and industry outlook.

The management emphasized plans to drive sustainable growth amid evolving market trends, aiming to strengthen stakeholder confidence.

No sensitive price details were shared.